New devices could help Penumbra take market share, according to physician survey

Penumbra’s new systems for removing blood clots from the veins and arteries received a positive reception, with doctors expecting to use the company’s devices more, according to a survey of 25 surgeons by J.P. Morgan. 

Scroll to Top